Roy Suryo
Dr Sarah Redvers, a safeguarding GP, has detailed her harrowing experience of being allegedly bullied, harassed, and ultimately forced out of her NHS child protection role after voicing concerns about the treatment of children experiencing gender distress. Speaking publicly for the first time, Dr. Redvers told the BBC that she faced a "brutal" investigation and felt she was "silenced" for diligently performing her duties by questioning the appropriateness of another GP’s assessments and treatments for young people grappling with their gender identity. Her ordeal has culminated in a constructive dismissal claim against the NHS Sussex Integrated Care Board (ICB) and its former chief executive, Adam Doyle.
During a three-week employment tribunal hearing, Dr. Redvers articulated her deep distress, stating that the intense focus on investigating her had tragically sidelined crucial patient safety issues. "I was just bewildered, really, that the medical and safeguarding issues were completely lost," she recounted, emphasizing the significant risks involved. In response, NHS Surrey and Sussex acknowledged that "some employment processes should have been handled differently" and offered an apology to Dr. Redvers.
The gravity of Dr. Redvers’s initial concerns was underscored in June 2026, nearly six years after she first raised them, when a separate, comprehensive NHS safety investigation revealed that dozens of children, some as young as 13, had been inappropriately prescribed powerful drugs at the WellBN practice, the clinic where the other GP worked. This damning report found that 78 children had potentially suffered harm due to the prescription of puberty-blocking drugs and cross-sex hormones without adequate checks and balances. The report explicitly stated it was a result of a drug review in autumn 2024, not directly in response to Dr. Redvers’s earlier whistleblowing. NHS England deemed the situation "totally unacceptable," highlighting that young people were put at risk because practitioners at WellBN provided care not commissioned by the NHS. Dr. Redvers expressed her profound sadness and frustration, stating, "To read about a medical scandal knowing it could have been stopped was upsetting, because concerns were raised appropriately and leaders knew about it."
Dr. Redvers, a seasoned professional with extensive experience working with vulnerable groups, served as a named safeguarding GP for Sussex. This role meant she was a trusted point of contact for other doctors seeking advice and support regarding patient safety concerns. The tribunal heard that in July 2020, a colleague approached her with worries about a patient. This vulnerable 18-year-old female, distressed about her gender identity, had sought treatment from an online clinic registered overseas. The referring doctor was asked to take over the prescription of testosterone for this patient, who had also received advice on such prescriptions from a Brighton-based GP, Dr. Sam Hall.
Dr. Redvers detailed her specific apprehensions: "The concerns to me were that Hall was recommending treatment for patients that he hadn’t assessed, that he hadn’t met, and that other GPs were uncomfortable with prescribing." Following advice from NHS England (NHSE), Dr. Redvers made a formal whistleblower complaint. This initial investigation by NHSE concluded that Dr. Hall’s practice was satisfactory.
However, over the subsequent months, a growing number of GPs continued to voice their concerns to Dr. Redvers. These worries centered on the quality of assessments, the prescription of puberty-blocking drugs and cross-sex hormones, and a perceived lack of specialist supervision at the WellBN clinic, where Dr. Hall was based. Once again, the NHS launched an investigation into these concerns. During this process, Dr. Redvers was informed by the investigator of a "general worry" that "there would be allegations of transphobia."
Dr. Sam Hall, who is a trans man and was born female, qualified as a GP in 2019 and has been an outspoken advocate for transgender rights in Brighton. Publicly, he has spoken about the importance of "affirmative care"—a patient-centered approach that accepts and validates a person’s gender identity and treatment preferences. He was also actively involved in local NHS initiatives to establish a Trans Health hub and collaborated with The Clare Project, a Brighton-based trans support charity.
The second NHS investigation, which examined "the full scope" of Dr. Hall’s work, found no cause for concern. Curiously, it also noted "one colleague whose persistent interest in the issue appeared disproportionate," which Dr. Redvers interpreted as a direct reference to herself. Dr. Redvers maintained that the core of her and her colleagues’ concerns was not about gender identity itself, but about the "medical assessment and treatment of patients, which is something we have to get right, particularly in this complex group of vulnerable patients." She vehemently rejected any suggestion of transphobia, describing it as "appalling" and "dangerous" for such claims to overshadow legitimate medical and safeguarding issues.
In 2021, while awaiting the outcome of the second investigation, and prompted by a concern raised by local mental health services regarding the care of a vulnerable 15-year-old, Dr. Redvers referred Dr. Hall to the General Medical Council (GMC), the medical regulator. Subsequently, Dr. Hall directly emailed Adam Doyle, then CEO of NHS Sussex, to lodge a complaint, stating, "I am being victimised here, and I need proper protection from this individual and their repeated attempts to disrupt my career." During the tribunal, it emerged that Mr. Doyle and Dr. Hall had a prior professional relationship, including several mentoring meetings, contradicting Mr. Doyle’s initial denial of knowing Dr. Hall.
The GMC investigation did not proceed. However, the NHS initiated its own investigation into Dr. Redvers, engaging an external investigator. Dr. Redvers described this process as a "brutal" four-hour interrogation, stating it was "oppressive, very upsetting. I didn’t feel I had the chance at all to explain what had happened. I broke down at one point." The ordeal left her off sick for several months, requiring trauma treatment. Notably, other colleagues interviewed as part of the investigation into Dr. Redvers also complained about the process, and the NHS upheld most of these complaints. The investigation’s conclusion recommended that the CEO and the trust apologize to Dr. Redvers and warned that her treatment could have a "broader negative impact" on staff willingness to raise concerns.
In 2023, a year after the grievance outcome, when a trans campaigner publicly labeled her as transphobic in an NHS meeting, Dr. Redvers felt the NHS failed to provide adequate support. This perceived lack of recourse led her to believe she had no option but to resign from her position as a safeguarding GP. "I just felt there’s no way I could carry on working in this organisation," she told the BBC. Around this same time, a group of parents, school governors, and social workers began raising their own concerns about WellBN and Dr. Hall.
Rachel Cashman, co-founder of the campaign group PSHE Brighton, expressed her dismay, stating, "It is a travesty that Sarah Redvers was punished for doing her job safeguarding and expecting the best standards of care for gender distressed children." Dr. Redvers is now awaiting the tribunal’s judgment, which could take several months. She described her experience as "personally and professionally difficult" and stressed that the NHS "needs to remember that patients come first" and should "listen to staff who raise legitimate concerns."
NHS Surrey and Sussex stated in their defense: "We engaged professionally and supportively with the Employment Tribunal. We recognise that some employment processes should have been handled differently and have apologised whilst Dr Redvers was employed with us, before, and during the hearings. We await the findings of the tribunal to make any further comment."
NHS England added: "When concerns about prescribing practices by an individual GP were escalated to NHS England national directors in 2023, they met directly with an affected family and asked regional professional standards leads to undertake formal investigations. Wider concerns were subsequently identified, and the WellBN practice was asked to stop providing a specialised prescribing service. Further new information led to NHS England and NHS Sussex initiating an independent patient safety investigation in 2025."
Dr. Sam Hall and WellBN were contacted for comment. In response to the June investigation report, WellBN acknowledged "the seriousness and sensitivity of the matters raised" and affirmed that its priority remained providing "compassionate, safe and effective care for all patients."
